Law & Politics The FDA’s data on mifepristone can’t be trusted — here’s why Nermeen Nabil June 18, 2026 For the review to withstand the necessary scrutiny it will face upon publication, the FDA must prioritize robust, real-world data sources. Continue Reading Previous: The Speedy Particles That Could Help Us Learn More About UranusNext: Obama Presidential Center opens Thursday: Here’s what to know Related Stories Law & Politics Ossoff: Trump ‘making a terrorist attack more likely’ with Pulte nomination Nermeen Nabil June 18, 2026 Law & Politics Top Foreign Relations Democrat on Trump’s Iran deal: ‘Catastrophically bad outcome’ Nermeen Nabil June 18, 2026 Law & Politics Vance warns Israeli officials against attacking Trump, their ‘only powerful ally’ Nermeen Nabil June 18, 2026